Does PASIREOTIDE Cause Neoplasm progression? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Neoplasm progression have been filed in association with PASIREOTIDE (Signifor LAR). This represents 1.6% of all adverse event reports for PASIREOTIDE.
30
Reports of Neoplasm progression with PASIREOTIDE
1.6%
of all PASIREOTIDE reports
10
Deaths
11
Hospitalizations
How Dangerous Is Neoplasm progression From PASIREOTIDE?
Of the 30 reports, 10 (33.3%) resulted in death, 11 (36.7%) required hospitalization, and 1 (3.3%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PASIREOTIDE. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does PASIREOTIDE Cause?
Hyperglycaemia (252)
Diabetes mellitus (224)
Blood glucose increased (219)
Diarrhoea (160)
Fatigue (160)
Nausea (150)
Headache (139)
Drug ineffective (132)
Dizziness (100)
Off label use (94)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which PASIREOTIDE Alternatives Have Lower Neoplasm progression Risk?
PASIREOTIDE vs PASIREOTIDE DIASPARTATE
PASIREOTIDE vs PATIROMER
PASIREOTIDE vs PATISIRAN
PASIREOTIDE vs PAXIL
PASIREOTIDE vs PAZOPANIB